Intracranial vessel wall MR imaging is an adjunct to conventional angiographic imaging with CTA, MRA, or DSA. The technique has multiple potential uses in the context of ischemic stroke and intracranial hemorrhage. There remain gaps in our understanding of intracranial vessel wall MR imaging findings and research is ongoing, but the technique is already used on a clinical basis at many centers. This article, on behalf of the Vessel Wall Imaging Study Group of the American Society of Neuroradiology, provides expert consensus recommendations for current clinical practice.
C onventional techniques for imaging the intracranial arteries are CTA, MRA, and DSA. These techniques reveal abnormalities of the vessel lumen, but they can fail to fully characterize disease that resides within the vessel wall. There has been growing interest in direct visualization of the vessel wall with high-resolution intracranial vessel wall MR imaging (VW-MR imaging). This technique is now used on a clinical basis at many centers.
In 2012, the American Society of Neuroradiology formed a multidisciplinary study group to support the development and clinical implementation of VW-MR imaging. This article, on behalf of the study group, reviews the principles of intracranial VW-MR imaging and provides consensus recommendations for clinical practice. We make these recommendations with the rec-ognition that there remain considerable gaps in knowledge and that research is ongoing.
TECHNICAL IMPLEMENTATION
The American Society of Neuroradiology Vessel Wall Imaging Study Group is working with MR imaging vendors to promote the development and dissemination of commercial pulse sequences that are optimized for intracranial VW-MR imaging. Until such sequences are widely available, it is possible to adjust the scan parameters of existing sequences and obtain vessel wall images of sufficient quality for clinical use. Selection of sequences and scan parameters for VW-MR imaging is highly dependent on the particular scanner hardware and software available at a center. The technical sections that follow provide general recommendations on the development of an intracranial VW-MR imaging protocol, and we are also launching a dynamic document (via the American Society of Neuroradiology Web site) through which experienced centers can describe their MR imaging systems and the specific pulse sequences and scan parameters that they have found useful.
The principal technical requirements for intracranial VW-MR imaging are the following: 1) high spatial resolution, 2) multiplanar 2D acquisitions or 3D acquisitions, 3) multiple tissue weightings, and 4) suppression of signal in luminal blood and CSF.
arising from neighboring blood and CSF within the voxel. In addition, vessel wall disease often results in wall thickening, which increases its conspicuity.
The higher signal-to-noise ratio at 3T than at 1.5T is advantageous for intracranial VW-MR imaging and, in many cases, necessary. At 3T with a 2D sequence, a voxel size of 2.0 ϫ 0.4 ϫ 0.4 mm provides a reasonable balance between spatial resolution and signal-to-noise ratio, with a scan duration of approximately 5-7 minutes for a 2-to 4-cm-thick section of tissue ( Fig 1A) . At 3T with a 3D sequence, a voxel size of 0.5 mm isotropic is a reasonable starting point ( Fig 1B) , and it is possible to cover the circle of Willis and second-/third-order branches in 7-10 minutes. Most experienced centers are using isotropic voxel dimensions in the 0.4-to 0.7-mm range for 3D acquisitions. Ongoing advances in MR imaging technology, including higher magnetic field strength, 2 may enable further increases in spatial resolution and image quality. 3 
Multiplanar 2D or 3D Acquisitions
Accurate interpretation of VW-MR imaging requires visualization of the vessel wall in both short-and long-axis planes. One option is to use 2D sequences multiple times in orthogonal planes, focusing on the particular vessels of interest. A limitation of this approach is that most intracranial arteries are curved rather than straight and vessel obliquity and curvature can result in partial volume averaging effects, 4 which confound the appearance of the arterial wall. Another option is to use a 3D (volumetric) sequence and then reformat the isotropic data for viewing in multiple 2D planes. The 3D approach reduces total scan time and provides more flexibility because any imaged vessel can be viewed in any reformatted plane. However, some groups have found that current 2D sequences provide better image quality when imaging is targeted to a particular vessel of interest. An optimal VW-MR imaging protocol may include both 2D and 3D sequences.
Multiple Tissue Weightings
Time-of-flight MRA is mainly used to characterize luminal abnormality and act as a localizer for subsequent vessel wall sequences. Low-velocity flow can cause intravascular signal loss on time-of-flight MRA, so in patients who have pronounced luminal narrowing or dilation, it is helpful to add a gadolinium-bolus MRA to accurately define the contour of the lumen (ie, the boundary between the lumen and wall). Most examinations require a T1-weighted vessel wall sequence before and after intravenous gadolinium contrast. It is possible to use a protondensity-weighted sequence instead of a T1-weighted sequence because the former provides higher SNR. The disadvantages of proton-density weighting are that contrast enhancement may be less conspicuous and CSF signal intensity can approach vessel wall intensity. A T2-weighted VW-MR imaging sequence is often helpful. Fat suppression is necessary for VW-MR imaging of the external carotid artery branches in the scalp (eg, in patients with suspected temporal arteritis) but is generally not needed for intracranial VW-MR imaging.
Suppression of MR Imaging Signal in Blood and CSF
MR imaging characterization of the vessel wall requires suppression of MR imaging signal arising from luminal blood and CSF (or brain parenchyma for a vessel residing adjacent to the brain) ( Fig 1C, -D) . Blood-suppression techniques usually exploit the condition of blood flowing and the vessel wall being stationary. Other techniques for blood suppression rely on the particular longitudinal relaxation time (T1) of blood, but these techniques usually have some dependence on flow as well. The most common methods of blood-signal suppression are the following:
Spin-Echo. Luminal spins that experience the section-selective 90°radiofrequency pulse but flow out of the imaging section before the section-selective 180°pulse do not yield signal, resulting in blood-signal suppression. 5 Spatial Presaturation (Saturation Band). A spatially selective pulse tips a thick slab of spins on either side of the imaging section into the transverse plane, and then a spoiling gradient dephases this transverse magnetization. 5 The dephased spins flow into the imaging section, where they are exposed to an excitation pulse, but they are not able to regain phase in the transverse plane until they have undergone longitudinal relaxation, so they do not yield signal.
Double Inversion Recovery Preparation. This technique exploits both the flow and T1 properties of blood to suppress its signal. 6 A 180°non-section-selective pulse inverts all spins. A section-selective 180°pulse, applied immediately after the first pulse, flips the imaging-section magnetization so it is realigned with the main magnetic field. There is then a time delay (TI), which allows inflowing inverted spins to relax to their null point; and at the expected null point for blood, another pulse is applied to generate an echo for readout. Only the stationary spins in the imaging section return signal. A disadvantage of the technique is that the time needed for spins to reach the null point lengthens the scan time, making it challenging to cover vessels of interest with sufficient spatial resolution for intracranial VW-MR imaging.
3D Sequences
The most commonly used 3D sequences for intracranial VW-MR imaging are the variable flip angle refocusing pulse, fast spin-echo sequences 7 with brand names such as VISTA (volume isotropic turbo spin-echo acquisition; Philips Healthcare, Best, the Netherlands), SPACE (sampling perfection with application-optimized contrasts by using different flip angle evolutions; Siemens, Erlangen, Germany), and Cube (GE Healthcare, Milwaukee, Wisconsin). These sequences have very long echo trains, a potential source of imaging blurring from decay of transverse magnetization between the start and end of the readout. These sequences minimize this blurring by varying the flip angle over the length of the echo train to maintain relatively stable signal.
Blood suppression techniques used with 2D sequences are generally less effective with 3D sequences. For example, spatial presaturation requires that spins in the imaging volume are replaced with inflowing suppressed spins, but this is unlikely to occur for the entirety of a large 3D imaging slab. However, other mechanisms can generate adequate blood suppression with 3D sequences. An important mechanism is intravoxel dephasing: Luminal blood contains spins traveling at varying velocities (eg, due to laminar flow). Between the time of excitation and readout, these spins move through the magnetic field gradients at different rates, resulting in intravoxel phase dispersion with signal loss. 8 One may further exploit the intravoxel dephasing effect by adding so-called diffusion-sensitizing gradient preparation to the 3D sequences. 9,10 This approach is similar to diffusion-weighted imaging, but the b-values are orders of magnitude lower, so the sequence suppresses bulk flow rather than molecular diffusion. Several centers have reported the details of how they optimized commercially available 3D sequences for intracranial VW-MR imaging. 11,12
Peripheral Pulse Gating
Most centers are currently performing intracranial VW-MR imaging without peripheral pulse gating. Pulse gating is potentially useful for VW-MR imaging of dilated intracranial arteries or large aneurysms in which gating to the point of maximum flow in the vessel may reduce the artifacts associated with slow flow and improve blood suppression.
Monitored Versus Unmonitored
When using 2D sequences, some groups monitor the examination and select the sequences and scan planes that will optimally show the vessels of interest. When using 3D sequences, monitoring is less critical but still sometimes helpful to determine coverage and select sequences.
SITUATIONS IN WHICH INTRACRANIAL VW-MR IMAGING IS LIKELY A USEFUL ADJUNCT TO CONVENTIONAL IMAGING

To Differentiate between Intracranial Atherosclerotic Plaque, Vasculitis, Reversible Cerebral Vasoconstriction Syndrome, Arterial Dissection, and Other Causes of Intracranial Arterial Narrowing
Atherosclerotic Plaque. Atherosclerotic plaque is composed of lipids, thrombotic substances (platelets and fibrin), cellular material, and connective tissue matrix. Plaque progression is often associated with the development of a well-defined region of lipid accumulation ("lipid core") within the plaque, a fibromuscular layer ("fibrous cap") separating the lipid from the arterial lumen, and intraplaque hemorrhage. [13] [14] [15] VW-MR imaging of intracranial atherosclerotic plaque typically demonstrates arterial wall thickening, which eccentrically (nonuniformly) involves the circumference of the arterial wall. The component of the plaque adjacent to the lumen is often hyperintense on T2-weighted images, and it may enhance (as discussed below), whereas the adjacent component is often hypointense on T2-weighted images and nonenhancing ( Fig 2F) . [16] [17] [18] [19] [20] [21] [22] There is sometimes a third thin layer in the periphery of the plaque that enhances. This layered appearance of intracranial atherosclerotic plaque correlates with the VW-MR imaging appearance of carotid atherosclerotic plaque, and carotid endarterectomy specimens have shown that the enhancing layer adjacent to the lumen represents fibrous cap, the nonenhancing layer adjacent to this represents lipid core, and the peripheral thin rim of enhancement is due to increased vasa vasorum in the adventitia of the artery. [23] [24] [25] Not every intracranial atherosclerotic plaque demonstrates all of these components on VW-MR imaging; for example, some plaques simply have the appearance of an eccentric homogeneously enhancing "lump" in the arterial wall. In addition, as we will discuss, not every intracranial plaque enhances.
The hypointensity-isointensity on T1-and T2-weighted images in the lipid core of atherosclerotic plaque differs from the MR imaging appearance of lipids in other tissues, such as subcutaneous fat, which is hyperintense on T1-weighted and T2-weighted fast spin-echo sequences. Two main factors likely account for this difference. First, even in relatively lipid-rich atherosclerotic plaque, the main contributor to MR signal is water protons and not lipid. 23 Second, the lipid in atherosclerotic plaque is mainly cholesterol and cholesteryl esters, which do not result in the same T1 shortening as extravascular lipid, which is composed mainly of triglycerides. 26 Vasculitis. Visualization of the wall of the smaller intracranial vessels is beyond the spatial resolution and SNR limits of current VW-MR imaging. However, CNS vasculitis often involves larger intracranial arteries that are amenable to wall imaging.
VW-MR imaging often demonstrates smooth, homogeneous, concentric arterial wall thickening and enhancement in patients with CNS vasculitis (Fig 2A-E) , in comparison with the typical nonconcentric (and often heterogeneous) wall abnormality of atherosclerotic plaque ( Fig 2F) . 19, 27, 28 However, subsequent experience has shown that vasculitis sometimes also results in eccentric wall abnormality. 29 The additional vessel wall features of atherosclerotic plaque on T1-, T2-, and enhanced sequences can be helpful for distinguishing between vasculitis and plaque.
Presumably, arterial wall enhancement in patients with CNS vasculitis is due to increased permeability of the endothelium with contrast leakage from the lumen into the arterial wall. Vasa vasorum-related contrast leakage is a potential alternative mechanism of wall enhancement, and dilated neovessels have been demonstrated within the extracranial arterial wall of patients with Takayasu arteritis. 30, 31 Reversible Cerebral Vasoconstriction Syndrome. Early discrimination between reversible cerebral vasoconstriction syndrome (RCVS) and its principal differential, vasculitis, is important: RCVS is treated with observation or calcium channel blockers, whereas vasculitis is treated with steroids and immunosuppressive drugs.
VW-MR imaging may enable prospective differentiation between vasculitis and vasoconstriction. 32 Both disorders result in arterial wall thickening, but the vessel wall in RCVS is typically nonenhancing (or mildly enhancing) compared with the typical intense wall enhancement in active vasculitis. 29, 32, 33 Arterial wall thickening with a lack of wall enhancement is consistent with the pathology of transient vasoconstriction. In vasospastic arteries, smoothmuscle cells shorten in length with increased overlap among cells, resulting in nearly a 500% increase in wall thickness for a 60% luminal narrowing. 32, 34 Lack of arterial wall enhancement is concordant with the limited histopathologic data in RCVS, showing an absence of arterial wall inflammation. 32, 35, 36 We have seen some individual cases that appear to be RCVS with more than minimal wall enhancement, so we recommend caution in relying strongly on VW-MR imaging discrimination between RCVS and vasculitis until this approach is validated in a larger study. Some study group members have also observed a crenelated appearance of arterial wall thickening in RCVS.
Moyamoya Disease. Initial VW-MR imaging studies of small numbers of patients with Moyamoya disease found a lack of arterial wall thickening and enhancement 19, 37 ; and a study found a smaller outer diameter of the vessel wall, less eccentricity of wall thickening, and less wall enhancement in patients with Moyamoya disease compared with atherosclerotic plaque. 38 Atherosclerotic plaque may undergo negative remodeling with reduction of the outer diameter of the vessel, but this seems to differ from Moyamoya disease, in which the MCA trunk is not visible at all in some cases, the so-called "vanishing MCA." 39 These VW-MR imaging findings are consistent with histopathologic studies showing thinning of the arterial media and a paucity of inflammatory cells in the vessel wall of patients with Moyamoya disease. 40 However, a subsequent study 41 found a considerably higher frequency of concentric internal carotid and middle cerebral artery wall enhancement in patients diagnosed with Moyamoya disease and, perhaps surprisingly, no difference in vessel wall enhancement between early and late angiographic stages of the disease. Further research is needed to resolve the discordance among studies. It will remain important to accurately differentiate between Moyamoya disease and the multitude of other causes of narrowing at the carotid terminus.
Radiation-Induced Arteriopathy. There is limited experience with the VW-MR imaging appearance of radiation-induced intracranial arteriopathy. A study 37 ever, it can also occur as an extension of cervical internal carotid artery dissection or as an isolated intracranial abnormality.
VW-MR imaging features of intracranial arterial dissection include a curvilinear hyperintensity on T2-weighted images (intimal flap) separating the true lumen from the false lumen and eccentric arterial wall thickening with the signal characteristics of blood (intramural hematoma) (Fig 3) . 42 A VW-MR imaging study 43 of 67 patients with intracranial arterial dissection suspected on CTA, MRA, or DSA found an intimal flap on luminal imaging in 16% of patients and on VW-MR imaging in 42%. VW-MR imaging demonstrated intramural hematoma in 61% of patients, with 83% of the visible hematomas evident on T1weighted images and 59% evident on T2-weighted images. The vessel wall abnormality had a layered appearance on contrastenhanced T1-weighted images, with enhancement along the luminal and peripheral margins of the artery wall in 51% of patients.
Intramural hematoma is often diagnosed on the basis of hyperintensity on T1-weighted images, but similar to other kinds of intracranial hemorrhage, the signal characteristics of intramural blood evolve with time. 44, 45 Among 7 patients with intracranial vertebral-basilar dissection, no patient had vessel wall hyperintensity on T1-weighted VW-MR imaging within a week of symptom onset, but 5 patients had hyperintensity in a subsequent
week. 46 T2*-weighted or susceptibilityweighted MR imaging is also sometimes useful for the diagnosis of dissection. The deoxygenation of blood that makes it conspicuous on these sequences occurs earlier than the conversion from deoxyhemoglobin to methemoglobin required for intramural hematoma to become hyperintense on a T1-weighted sequence. 47 The evolution of blood products is also complicated by the dynamic nature of dissection itself, which can be stable, progressive, or resolving. Intracranial arterial dissection with VW-MR imaging evidence of intramural hematoma is more likely to progress than dissection without hematoma. 48
To Identify Symptomatic, Nonstenotic Disease of the Intracranial Arteries
In 15 patients with an acute lacunar infarct, normal angiography findings, and no other apparent cause of stroke, VW-MR imaging demonstrated enhancing atherosclerotic plaque in the supplying (middle cerebral or basilar) artery in 9 (60%) patients. 49 Similar studies have shown VW-MR imaging evidence of atherosclerotic plaque in the supplying artery of 52% of patients with MCA territory lacunar infarcts and 42% of patients with pontine infarcts, but normal MRA findings. 50, 51 A VW-MR imaging study 52 that assessed the prevalence of MCA plaque both ipsilateral and contralateral to lenticulostriate territory infarcts in patients who had normal MRA findings found a similar prevalence (46% and 45%, respectively) bilaterally. This latter study did not report whether there was a difference in contrast enhancement between the plaques ipsilateral versus contralateral to the infarction. Figure 3 demonstrates VW-MR imaging identification of a culprit plaque when angiographic findings are normal. Study group members have also found that VW-MR imaging can help diagnose cases of CNS vasculitis and arterial dissection with minimal arterial luminal abnormality. Figure 4 demonstrates VW-MR imaging diagnosis of symptomatic intracranial arterial dissection in the context of a CTA considered equivocal for luminal narrowing.
SITUATIONS IN WHICH INTRACRANIAL VW-MR IMAGING IS POSSIBLY A USEFUL ADJUNCT TO CONVENTIONAL IMAGING
To Determine the Location of Atherosclerotic Plaque Relative to Branch Artery Ostia, to Diagnose Stroke Etiology, and to Assess Risk of Angioplasty
In the coronary circulation, atherosclerotic plaque most often develops in the arterial wall opposite a branch artery ostium. 53 Similarly, intracranial VW-MR imaging has shown that MCA plaque is more common in the ventral (45%) or inferior (32%) parts of the wall than in the superior (14%) or dorsal (9%) parts where branches arise, 54, 55 and basilar artery plaque is more common in the ventral part of the wall, which is opposite the origins of the branches. 56 However, some atherosclerotic plaque does arise close to ostia, and VW-MR imaging has confirmed that indeed MCA plaque with associated infarction has more superior wall involvement than plaque without infarction (24% versus 7%). 54 Angioplasty can generate a "snow plow" effect, in which atheromatous material is pushed from the treated artery into a branch. In the coronary circulation, location of atherosclerotic plaque close to a branch ostium increases the risk of branch occlusion following angioplasty and stent placement. 57 By determining the location of intracranial atherosclerotic plaque relative to branch ostia in individual patients, VW-MR imaging may be useful when estimating the risk of intracranial angioplasty. 58
To Assess Atherosclerotic Plaque Activity
Higher risk intracranial atherosclerotic plaque shares pathologic features with higher risk carotid plaque. 59 Several imaging features may indicate higher-risk plaque.
Plaque Thickness and Surface Irregularity. Most VW-MR imaging studies 20,21 suggest that symptomatic intracranial plaque is thicker than asymptomatic plaque, though some 60 have found no significant relationship. A study of 14 patients with symptomatic MCA stenosis and 16 patients with asymptomatic stenosis found plaque surface irregularity (discontinuity of the plaque luminal surface margin) in 71% of symptomatic patients but in only 19% of asymptomatic patients (P ϭ .008). 61 Vessel Wall Remodeling. Atherosclerotic plaque often results in outward bulging of the outer surface of the artery. 62 This has been called compensatory enlargement ("adaptive remodeling" or "positive remodeling") because it can lessen the luminal narrowing caused by the plaque. In the coronary arteries, positive remod-eling is more common in plaques that contain hemorrhage and inflammation 63 ; this feature suggests that positive remodeling is an indicator of higher risk vessel wall pathology. Other plaques are associated with reduction of the outer diameter of the artery ("negative remodeling"), 64 and this may reflect a fibrotic healing response. Most VW-MR imaging studies 20,61 have found that MCA remodeling was (on average) outward in symptomatic plaques and inward in asymptomatic plaques, though some studies 16 have found no significant difference. Microembolic signals on transcranial Doppler sonography were more common in patients with MCA atherosclerotic plaque with VW-MR imaging evidence of positive remodeling, 65 consistent with the idea that positive remodeling is characteristic of the higher risk plaque that produces thromboembolism.
Intraplaque Hemorrhage. A postmortem study of MCA atherosclerosis found intraplaque hemorrhage in 30% of plaques associated with an infarct compared with 15% of plaques not associated with an infarct (P ϭ .07). 66 A VW-MR imaging study of 107 adults with Ͼ70% MCA stenosis found that T1 shortening (thought to indicate intraplaque hemorrhage) was more common in symptomatic than in asymptomatic plaque (20% versus 2%, P ϭ .01). 66 Another study reported a higher prevalence of intraplaque T1 shortening in symptomatic-versus-asymptomatic MCA plaques (27% versus 0%, P ϭ .002). 60 In a research context, a signal intensity of Ͼ150% of the signal intensity of adjacent gray matter 60 or scalp muscle 66 on a T1-weighted sequence has been used as a criterion for defining intraplaque hemorrhage. Several study group members have observed a much lower prevalence of intracranial intraplaque hemorrhage than the values reported in the literature, possibly due to different patient populations or timing of the scans relative to symptom onset. adventitia (though sometimes in the middle of the plaque) and is a marker of inflammation and neovascularization. 25, [67] [68] [69] A postmortem study 59 found that neovascularity in MCA atherosclerotic plaque was associated with ipsilateral infarction. VW-MR imaging studies 19, 70, 71 have shown that intracranial plaque enhancement is associated with recent infarction in the territory of the plaque.
A study of the temporal characteristics of intracranial plaque enhancement found strong enhancement within 1 month of ischemic stroke and reduced enhancement several months later. 72 Another study 73 found no difference in enhancement when comparing patients with acute stroke versus those with stroke any time in the preceding 3 months, which is not inconsistent with the former study, which found that enhancement did not lessen until a few months after the acute event.
In some intracranial plaques, one can identify the enhancing fibrous cap and enhancing adventitia as distinct layers on either side of an intervening nonenhancing layer, but (possibly due to the limited spatial resolution of VW-MR imaging relative to the size of intracranial plaques) plaques often appear to enhance diffusely or not at all.
To Assess Vasculitis Activity
A small number of published cases 29 and the broader experience of the study group suggest that there may be a discordance between intracranial VW-MR imaging findings and the clinical impression of vasculitis disease activity. This is consistent with extracranial VW-MR imaging observations. An extracranial VW-MR imaging study of 24 patients with Takayasu arteritis found arterial wall edema (hyperintensity on T2-weighted images) in 94% of VW-MR imaging examinations performed in patients with clinically active disease and in 56% of examinations performed in those without clinically active disease. 74 There was also greater wall enhancement in those with clinically active disease. The high prevalence of wall edema in patients without clinically active disease may not be misleading though: In a different study, biopsy specimens revealed histopathologic evidence of active vasculitis in 44% of patients with Takayasu arteritis who had no clinical evidence of active disease. 75 Similarly, a study found new stenotic lesions on serial angiography in 61% of patients who were in clinical remission. 76 The effects of treatment on inflammatory VW-MR imaging findings are potentially important. Intracranial VW-MR imaging data are lacking, but the sensitivity of extracranial VW-MR imaging for the diagnosis of temporal arteritis was lower in patients who were imaged Ͼ2 days after starting corticosteroid treatment. 77
To Select an Intracranial Target for Biopsy in Suspected CNS Vasculitis
Extracranial VW-MR imaging has been used to identify an inflamed segment of the superficial temporal artery and guide arterial biopsy to diagnose giant cell arteritis. 78 There is a lack of high-quality data on the sensitivity and specificity of brain (or leptomeningeal) biopsy for the diagnosis of CNS vasculitis. However, CNS vasculitis can be spatially heterogeneous, and falsenegative biopsies occur. Study group members have found that VW-MR imaging is a potential means of identifying a peripherally located inflamed vessel to target for biopsy.
To Determine Which Aneurysm Has Ruptured in Patients with Acute Subarachnoid Hemorrhage and Multiple Aneurysms
There has been more experience with intracranial VW-MR imaging in the context of ischemic stroke than subarachnoid hemorrhage. However, preliminary results suggest that VW-MR imaging may be a useful technique for evaluating patients with intracranial aneurysms. An initial study 79 used a 2D double inversion recovery VW-MR imaging sequence at 1.5T with a voxel size of 0.5 ϫ 0.6 ϫ 0.3 mm to image the wall of saccular aneurysms, and there have been subsequent studies of the berry aneurysm wall at 3T and 7T. 80 A VW-MR imaging study 81 of 5 patients with aneurysmal subarachnoid hemorrhage found that all ruptured aneurysms demonstrated thick peripheral enhancement. Three patients in this series had multiple aneurysms, and the unruptured aneurysms did not enhance. A subsequent study 82 confirmed these findings in a larger sample size: There was aneurysm wall enhancement in 16/17 ruptured aneurysms; enhancement in 5/5 unruptured aneurysms that had changed in morphology compared with a previous angiogram; and enhancement in 6/9 symptomatic unruptured aneurysms; but wall enhancement in only 22/77 unrup- , arrow) . Axial T2-weighted FLAIR image (E, arrow) demonstrates a hematoma centered around the enhancing aneurysm, consistent with the preliminary research studies, suggesting that symptomatic and ruptured aneurysms have wall enhancement much more commonly than asymptomatic saccular aneurysms. tured, asymptomatic, stable aneurysms. Another study 10 had similar results. Figure 5 provides an example of VW-MR imaging in a patient with 2 aneurysms, 1 unruptured and 1 ruptured.
There has also been interest in using VW-MR imaging to determine the source of hemorrhage in patients with angiogramnegative non-perimesencephalic subarachnoid hemorrhage, 83 but no evidence yet of utility.
SITUATIONS IN WHICH INTRACRANIAL VW-MR IMAGING IS CURRENTLY IN THE DOMAIN OF RESEARCH
To Predict Future Behavior of Unruptured Intracranial Saccular Aneurysms
A study of human aneurysm tissue found diffuse invasion of macrophages and leukocytes into the vessel wall of ruptured aneurysms but few inflammatory cells in the wall of unruptured aneurysms. 84, 85 These inflammatory changes were already present shortly after the rupture and were not more pronounced when there was greater time between aneurysm rupture and surgical excision, suggesting that aneurysm wall inflammation might precede rupture rather than occur as a result of rupture. 84 If aneurysm wall inflammation is an important factor in aneurysm growth and rupture, then vessel wall enhancement may be a marker of rupture risk. However, prospective longitudinal studies are needed to prove that this is correct.
There is also interest in measuring aneurysm wall thickness to predict rupture risk. However, berry aneurysm wall thickness is approximately 0.02-0.5 mm, 86 leading to overestimation of wall thickness from the partial volume effects that will occur at the spatial resolutions currently achievable. 87 It is not yet possible to accurately measure berry aneurysm wall thickness by using VW-MR imaging.
IMPORTANT PITFALLS
Accurate diagnosis by using VW-MR imaging is critically dependent on both an adequate imaging technique and interpretive experience. When either of these is lacking, normal variations are easily misinterpreted as disease.
Slow Flow
Most VW-MR imaging techniques rely on blood flow to achieve blood-signal suppression. Blood flow is often laminar, with lower velocity closer to the vessel wall. Incomplete signal suppression in the periphery of the lumen can mimic vessel wall thickening and/or wall enhancement ( Fig 6A, -B) . Factors predisposing to these artifacts include recirculating or slow flow within an aneurysm, low velocity flow in a dilated artery, and retrograde filling of a branch artery via leptomeningeal collaterals when there is proximal arterial occlusion. 88
Vasa Vasorum
The walls of major extracranial arteries receive blood supply through the vasa vasorum, a network of small vessels within the outer aspect of the vessel wall itself. Intracranial vessels in children lack a vasa vasorum. 89 However, with increasing age and with atherosclerotic risk factors, extracranial vasa vasorum can extend into the proximal intracranial segments of the internal carotid and vertebral arteries. 90 In patients with a variety of intracranial arterial diseases, a vasa vasorum can also develop distant from the extracranial vasa vasorum, with supply from nearby intracranial arteries. 91 A vasa vasorum can cause concentric arterial wall thickening and enhancement, 92 which mimic vasculitis ( Fig 6C) . shows that the crescent of apparent arterial wall thickening fills with contrast and therefore represents a dilated basilar artery lumen rather than the arterial wall. Case 2 (C) shows how vasa vasorum can mimic vasculitis. Coronal contrast-enhanced T1-weighted VW-MR imaging shows a focal atherosclerotic plaque (white arrow) of the basilar artery, but also more diffuse smooth concentric enhancement of the vertebral (black arrows) and basilar artery walls, which has an appearance similar to that of vasculitis. The diffuse enhancement is consistent with increased intracranial vasa vasorum in this patient who has strong atherosclerotic risk factors. Case 3 (D) shows how a normal vein residing close to an artery can mimic arterial wall disease, such as enhancing atherosclerotic plaque. Axial contrast-enhanced T1-weighted VW-MR imaging shows a vein (arrow) adjacent to the left middle cerebral artery.
Veins
An enhancing vein located adjacent to an artery can mimic arterial wall enhancement ( Fig 6D) . It is usually possible to avoid this by careful examination of VW-MR imaging in multiple planes and comparison with MR angiography.
Effects of Thromboembolism and Thrombectomy on the Arterial Wall
Does thromboembolism itself injure the arterial wall and change the appearance of the wall? Does mechanical thrombectomy alter the appearance of the wall? These issues were explored in a VW-MR imaging study of 16 patients imaged within days of acute intracranial arterial occlusion. 93 The cause of stroke was an extracranial source of thromboembolism in most cases, and the intracranial arteries had fully recanalized at the time of VW-MR imaging in most cases. The study found that mechanical thrombectomy results in concentric intracranial arterial wall thickening and enhancement, potentially mimicking the VW-MR imaging appearance of primary arteritis. A similar arterial wall abnormality was observed in patients treated with medical therapy alone, but it was less common in this group.
RECOMMENDATIONS FOR CLINICAL PRACTICE
Intracranial VW-MR Imaging Is Likely a Useful Adjunct to Conventional Imaging
1) To differentiate among causes of intracranial arterial narrowing such as intracranial atherosclerotic plaque, vasculitis, reversible cerebral vasoconstriction syndrome, and arterial dissection.
2) To identify symptomatic, nonstenotic disease of the intracranial arteries.
Intracranial VW-MR Imaging Is Possibly a Useful Adjunct to Conventional Imaging
1)
To determine the location of atherosclerotic plaque relative to branch artery ostia.
2) To assess atherosclerotic plaque activity.
3) To assess vasculitis activity. 4) To select an intracranial target for biopsy in suspected CNS vasculitis. 5) To determine which aneurysm has ruptured in patients with acute subarachnoid hemorrhage and multiple aneurysms.
Intracranial VW-MR Imaging Is Currently in the Domain of Research
1) To predict future behavior of unruptured intracranial saccular aneurysms.
Technical Implementation
1) Use pulse sequences that provide sufficient spatial resolution, black blood, and preferably black CSF.
2) Use 2D sequences in short-and long-axis planes through the vessels of interest, and/or 3D sequences with isotropic voxel dimensions and multiplanar reformatting.
3) Modify the VW-MR protocol in response to the particular clinical indication. Protocols will often include a time-of-flight MRA of the circle of Willis, T1-weighted (or proton-density-weighted) vessel wall sequences before and after intravenous administration of gadolinium, and T2-weighted sequences. Consider adding a gadolinium-bolus MRA, particularly if there is severe arterial narrowing or arterial dilation. 4) Recognize that the true performance capabilities of MR images are often unclear and important characteristics such as spatial resolution depend on multiple factors and not simply voxel size. Therefore, quantitative measurements (such as vessel wall thickness) should be validated against calibration standards by using phantom testing.
Interpretation 1) Interpret VW-MR imaging using the fundamental principles of radiologic interpretation used in other body tissues. Confirm vessel wall findings in multiple planes and preferably with multiple tissue weightings, and combine information from all available sequences to determine whether there is vessel wall thickening or enhancement. This assessment requires accurate determination of the inner and outer boundaries of the vessel wall by direct comparison of T1-, T2-, and contrast-enhanced T1weighted images and MRA source images. For accurate interpretation, it is critical to harmonize observed abnormalities across all sequences.
2) Recognize common pitfalls such as age-related vasa vasorum enhancement in the large intracranial arteries near the skull base, slow flow mimicking arterial wall thickening or enhancement, normally enhancing veins that are commonly seen close to arteries, and the effects of therapy on the vessel wall.
3) Always seek knowledge of the broader clinical context of the VW-MR imaging. 4) Communicate VW-MR imaging results to referring physicians along with the appreciation that certain VW-MR imaging findings are well-studied but others (which may still be important) are not yet fully validated. 
